In Lille, since August 10, a pharmacy tests, like four others in France, the feasibility of a vaccination against the monkeypox virus in these pharmacies.
p>
On the Place de la Gare bordered by narrow and high buildings, the Grande Pharmacie de Paris, in Lille, occupies a privileged position. At the crossroads of two large railway stations, two metro lines and a tram line, its accessibility is a precious asset. It was retained, in fact, to participate in an experiment that started on August 10: with four other pharmacies, it tests the feasibility of a vaccination against the Monkeypox virus (“monkey variole”) by city pharmacies.
Inside, a few young men wait, in a discreet line, in front of the parapharmacy stands. “I come from Brussels, half an hour by train, testifies Philippe, 38 years old. In Belgium, the stocks of the new generation vaccine against the smallpox are very insufficient. I made an appointment on Doctolib and obtained very quickly A place. Being vaccinated will reassure me. “Behind him, Marc, 42, also comes from Belgium; Same thing for Thierry, 33 years old: “I was informed by Instagram of the opening of this vaccination, he explains. For me, it is security.”
“Are you right -wing or left -handed?” Asks Amaury, assistant pharmacist, in a small blind room nestled behind the sales area. “Right -handed”, replies Marc. After disinfection, Amaury stings the young man’s left shoulder and gently pushes the piston. “The vaccine is injected under the skin, it really does not hurt, he explains. At most, it may swell a little in the coming hours.” What confirms Philippe, bright blue look, smiling behind The mask: “It’s a little bit of nothing at all!”
“There is a strong expectation, notes Fabien Florack, titular pharmacist, manager of the Lille pharmacy. When we opened the first slots, they were taken in less than two days.” This pharmacy was also chosen for Its important active line of patients treated for HIV or who follow preventive treatment. “This population corresponds to the target audience of vaccination against the variole of the monkey. On this sensitive subject, our experience gives us know-how.”
Tempo chisle, but which accelerates
Identified in early May, the monkey’s smallpox epidemic concerns a growing number of countries and people. As of August 19, 40,756 cases were postponed in 96 countries, including 19,870 in Europe. In France, 2,749 confirmed cases were identified on August 16. The Ile-de-France region concentrated the largest number of cases (1,642), followed by Occitanie (244 cases) and Auvergne-Rhône-Alpes (213 cases). All are adult men (median age: 36 years old), except 29 women and four children under the age of 15. To date, 53 people (3 %) have had to be hospitalized, but no death has been reported in France.
You have 66.12% of this article to read. The continuation is reserved for subscribers.